时间标签：数据日期 2026-10-31 · 生成时间 2026-11-01 05:30（Asia/Shanghai）｜ 检索窗口 PubMed edat 2026/10/28–2026/10/31 ｜ 情报发生日期 2026-10-31
研究问题
We need to know if and how they already access neuroscience research in response to policy challenges they are facing in their communities, as well as if they would like to engage more than they currently are.
方法
We conducted four nationally representative surveys of policymakers from July 29, 2025, to October 13, 2025.；The sample of local elected policymakers (N = 366) is randomly drawn from a comprehensive list of local elected officials in US township, municipality, and county governments serving communities of 1,000 or more.；The sample of state legislators (N = 267) is randomly drawn from a comprehensive list of legislators in all 50 states.；CivicPulse recruited all respondents via email (with one initial email and two follow-ups) and used its standard consent language.
核心结论
These response rates meet and/or exceed those from other nationwide surveys of state and/or local policymakers recently published in several high impact journals (which are between 7 and 13%; ; ; ).；Across all four types of policymakers, direct interaction with a neuroscientist was the least common recent type of engagement (with just one exception—slightly more state legislators had directly interacted with a neuroscientist at least once over the past year than had learned about neuroscience research via blogs): 13.8% of local elected officials (95% CI: 10.3, 18.4%), 19.7% of local staff (95% CI: 12.4, 29.8%), 28.6% of state legislators (95% CI: 22.5, 35.6%), and 18.2% of state staff (95% CI: 12.2, 26.2%) reported that they had interacted with a neuroscientist at least once over the past year. ‖ 结论：Overall, our results suggest that, when working to protect and promote the health of their communities, many policymakers are not currently engaged with neuroscience but would like to be.
局限
We were mindful that some policymakers may not be very familiar with neuroscience and the overlap of its purview with their work.；This description read as follows (in which “[decision-makers]” was filled in as appropriate for each sample): Notably, this paragraph also employed language to acknowledge and legitimize that some policymakers may engage with neuroscience research and others may not.
对本项目的价值
★☆☆☆☆ 相关范围内，作为背景与横向对照收录。
全文来源
PMC JATS 全文（正文 20,730 字符，已过标题/DOI 逐字归属校验）
原文题录
- 英文标题：State and Local Policymakers' Engagement with Neuroscience to Improve Health Policy in the United States.
- 期刊与标识：eNeuro · PMID 42957287 · DOI 10.1523/eneuro.0282-26.2026
B 级证据分级：B 级（同行评议临床前研究，主要为动物模型）
本文核心结论来自动物模型或体外细胞学，属临床前证据，不能外推至人体。「延长健康寿命」「改善功能」等表述在小鼠中的意义，与人类临床结局之间仍有距离。
关于本文的文献来源：本站依据 IMA 知识库「五刊监控·深度文献卡片」撰写，依据已获取的期刊全文（方法、样本量与结论已回到原文核对）；未能获取全文的同批条目另行标注「摘要级」，全程未做任何数值推算补全。